title: [Erythroleukemia in a patient with Behçet's disease under long-term thalidomide therapy].
authors.forename: B
authors.initials: B
authors.lastname: Louzir
authors.forename: S
authors.initials: S
authors.lastname: Othmani
authors.forename: N
authors.initials: N
authors.lastname: Gritli
authors.forename: M
authors.initials: M
authors.lastname: Beji
authors.forename: B
authors.initials: B
authors.lastname: Zidi
authors.forename: F
authors.initials: F
authors.lastname: M'Saddek
authors.forename: E
authors.initials: E
authors.lastname: Boussema
authors.forename: M
authors.initials: M
authors.lastname: Bahri
mesh_terms: D000328:Adult; D001528:Behcet Syndrome / Q000188:drug therapy*; D006801:Humans; D004915:Leukemia, Erythroblastic, Acute / Q000139:chemically induced*; D008297:Male; D013792:Thalidomide / Q000009:adverse effects*; D013997:Time Factors
chemical_list: D013792:Thalidomide
vernacular_title: Erythroleucémie chez un patient ayant une maladie de Behçet et traité au long cours par thalidomide.